Staff Scientist
EPIDEMIOLOGY AND BIOSTATISTICS PROGRAM
National Cancer Institute
United States of America
Dr. Troisi received a Sc.D. from the Harvard School of Public Health in 1994 and joined NCI the same year. Her research has focused on the hormonal etiologies of reproductive cancers and the role of maternal, gestational, neonatal and early life factors in breast cancer risk, including endocrine disruptors such as diethylstilbestrol, a drug previously given to pregnant women. Dr. Troisi and colleagues Dr. Marlene Goldman and Dr. Kathryn Rexrode edited the second edition of Women and Health, a comprehensive review of the behavioral, social, and biological determinants of health and well-being in women, published in late 2012 by Elsevier. She received NIH Merit Awards in 2011 and 2012.
Hormonal etiologies of reproductive cancers; The role of maternal, gestational, neonatal and early life factors in breast cancer risk, including endocrine disruptors such as diethylstilbestrol (DES); The biology of early life risk factors and implications for cancer risk